Evaluation of Monocyte Expression of HLA-DR (mHLA-DR) in Geriatric Service

Last updated: January 29, 2025
Sponsor: Hospices Civils de Lyon
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Blood sampling

Clinical Study ID

NCT06513520
69HCL24_0650
ID RCB
  • Ages > 75
  • All Genders

Study Summary

The acceleration of population aging and the improved management of comorbidities lead to an increase in the number of multi-pathological elderly patients admitted to geriatric services. This is an extremely specific population in terms of immunology due to the presence of immunosenescence (physiological aging of the immune system) and the potential additional effect of multiple chronic pathologies (comorbidities) presented by these patients.

The specific effect of multiple chronic pathologies on the immune status of elderly patients is currently underexplored because most studies on immune system aging only include elderly patients who do not have comorbidities or treatments that could impact the immune system (e.g. SENIEUR protocol). Therefore, their results are not applicable to patients in geriatric services.

The decrease in monocyte expression of HLA-DR (mHLA-DR) has been studied as a marker of immune alteration in intensive care units in the context of sepsis, but also in chronic pathologies (e.g. cancer, diabetes, renal insufficiency). These chronic pathologies are frequently found in elderly subjects.

The objective of the study would therefore be to investigate the relative contribution of age (immunosenescence) and comorbidities to the alteration of the immune status of geriatric patients through the measurement of mHLA-DR.

To date, no study has explored mHLA-DR in a population of multi-pathological geriatric patients. Our work aims to generate initial data through a pilot study in hospitalized multi-pathological subjects over 75 years old in geriatric services.

Eligibility Criteria

Inclusion

Inclusion Criteria:

For all patients:

  • Patients aged over 75 hospitalised in one of the geriatric units defined as theresearch sites;

  • Patient affiliated to a social security scheme;

  • Patients or relatives who have been informed and have no objections to the research.

To be eligible in the acute situation sub-population:

  • Patients presenting with an acute episode on admission or following a stay in theresearch sites; The acute episode is defined, for example, by an infection, cardiacdecompensation, a complicated fall, acute renal failure, any acute or decompensatedcardiovascular pathology, any discovery of cancer that has not been stabilised.

To be eligible in the stable situation sub-population:

  • A patient who has not had an acute episode for at least 7 days.

Exclusion

Exclusion Criteria:

For all patients:

  • Patients under legal protection: curatorship, guardianship, safeguard of justice ;

  • Patients under exclusive comfort care for whom it has been decided not to take ablood sample;

  • Patients undergoing long-term antibiotic treatment, i.e. with no defined stoppingdate;

  • An immunocompromised patient or a patient undergoing immunosuppressive treatment (for example: HIV infection, a patient awaiting solid organ transplantation, apatient undergoing haematopoietic stem cell transplantation, a patient undergoingchemotherapy for a solid tumour or haematological malignancy, a patient sufferingfrom an auto-immune disease and being treated with immunotherapy and/orimmunosuppressive therapy and/or biotherapy, an asplenic or hyposplenic patient, apatient undergoing experimental potentially immunosuppressive treatment, a patientundergoing Eculizumab treatment, a patient presenting a hereditary immunedeficiency).

For patients in an acute clinical situation:

  • Patient previously included in the same sub-population.

Study Design

Total Participants: 120
Treatment Group(s): 1
Primary Treatment: Blood sampling
Phase:
Study Start date:
January 06, 2025
Estimated Completion Date:
January 31, 2026

Connect with a study center

  • Dugoujon Hospital

    Caluire-et-Cuire, 69300
    France

    Active - Recruiting

  • Croix Rousse hospital

    Lyon, 69004
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.